Cardinal Health 2010 Annual Report Download - page 24

Download and view the complete annual report

Please find page 24 of the 2010 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 130

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130

CARDINAL HEALTH, INC. AND SUBSIDIARIES
GAAP / NON-GAAP RECONCILIATION
Fiscal year 2010 GAAP
Restructuring
and employee
severance
Acquisition-
related
costs
Impairments
and (gain) / loss
on sale of assets
Litigation
(credits) /
charges, net
Other
spino
costs
Gain on
sale of
CareFusion
stock
Non-
GAAP
Operating earnings
Amount $1,307 $91 $8 $29 ($62) $11 — $1,383
Growth rate 1 % (2)%
Diluted EPS from continuing operations
Amount $1.62 $0.16 $0.02 $0.09 ($0.11) $0.56 ($0.12) $2.22
Growth rate (23)% (2)%
Fiscal year 2009 GAAP
Restructuring
and employee
severance
Acquisition-
related
costs
Impairments
and (gain) / loss
on sale of assets
Litigation
(credits) /
charges, net
Other
spino
costs
Gain on
sale of
CareFusion
stock
Non-
GAAP
Operating earnings
Amount $1,287 $105 $3 $14 $5 $5 — $1,419
Growth rate (8)% (1)%
Diluted EPS from continuing operations
Amount $2.10 $0.21 — ($0.07) $0.01 $0.01 — $2.26
Growth rate (10)% (8)%
Fiscal year 2008 GAAP
Restructuring
and employee
severance
Acquisition-
related
costs
Impairments
and (gain) / loss
on sale of assets
Litigation
(credits )/
charges, net
Other
spino
costs
Gain on
sale of
CareFusion
stock
Non-
GAAP
Operating earnings
Amount $1,392 $55 $3 ($33) $20 — — $1,437
Diluted EPS from continuing operations
Amount $2.33 $0.17 — ($0.05) — — — $2.45
The sum of the components may not equal the total due to rounding.
(in millions, except per Common Share amounts)
Important notice regarding forward-looking statements
This annual report contains forward-looking statements, which are not based on historical facts, addressing expectations, prospects, estimates and other matters that are
dependent upon future events or developments. These statements may be identi ed by words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “will,” “should,”
“could,” “would,” “project,” “continue,” and similar expressions, and include statements re ecting future results or guidance, statements of outlook and tax accruals. These
matters are subject to risks and uncertainties that could cause actual results to di er materially from those projected, anticipated or implied. These risks and uncertainties
include (but are not limited to) the ability to achieve the expected bene ts from the acquisition of Healthcare Solutions Holding and to grow our specialty distribution
business; uncertainties and risks regarding the e ect of the CareFusion spino on Cardinal Health; the performance of CareFusion and the proceeds realized from future
sales of CareFusion stock; uncertainties due to government healthcare reform including the recently enacted federal healthcare reform legislation; competitive pressures in
Cardinal Health’s various lines of business; the loss of one or more key customer or supplier relationships or changes to the terms of those relationships; the timing of generic
and branded pharmaceutical introductions and the frequency or rate of branded pharmaceutical price appreciation or generic pharmaceutical price de ation; changes in
the distribution patterns or reimbursement rates for healthcare products and/or services; the results, consequences, e ects or timing of any inquiry or investigation by any
regulatory authority or any legal or administrative proceedings; the e ects of disruptions in the  nancial markets, including uncertainties related to the availability and/
or cost of credit on Cardinal Health’s customers and vendors; and uncertainties related to demand for Cardinal Health’s products and services. In addition, Cardinal Health
is subject to additional risks and uncertainties described in Cardinal Health’s Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and
exhibits to those reports. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement.
23